跳到主要內容

Maetzold Derek J 的 Form 4 申報

Castle Biosciences IncCSTL,2026/11/4 申報

申報編號
0001628280-26-070131
申報時間
2026/11/4 16:07 ET
交易日
2026/11/2
申報延遲
2 天
10b5-1 計畫
有勾選

這份申報列了 6 筆非衍生性交易。公開市場賣出合計 $52.3 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Maetzold Derek JCIK 0001239501董事、高階主管(總裁、執行長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/11/2Common StockS賣出處分−7,555$36.01F2−$272,017.784,929直接
2026/11/2Common StockS賣出處分−2,816$36.01F2−$101,390.082,024間接
2026/11/2Common StockS賣出處分−2,393$36.01F2−$86,159.971,721間接
2026/11/2Common StockS賣出處分−1,025$36.81F5−$37,734.353,904直接
2026/11/2Common StockS賣出處分−382$36.81F5−$14,062.951,642間接
2026/11/2Common StockS賣出處分−325$36.81F5−$11,964.551,396間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

This transaction was executed in multiple trades at prices ranging from $35.610 to $36.593, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 3 筆交易的價格引用這則附註。

F5

This transaction was executed in multiple trades at prices ranging from $36.610 to $37.030, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 3 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)